Zelnorm bares its belly
Executive Summary
Novartis' Zelnorm (tegaserod) DTC campaign emphasizes the symptoms of constipation-predominant irritable bowel syndrome. The television ads depict close-ups of women lifting their shirts and displaying words written on their stomachs. Messages include "I'm all twisted inside," "the bloating is so uncomfortable," and "I keep thinking about the pain" in Novartis' first branded campaign for IBS therapy (1"The Pink Sheet" July 28, 2003, p. 34)...
You may also be interested in...
Novartis Sales Growth Strategy Is DTC Ads, “Cleverly Crafted” Phase IVs
Novartis is considering expanded use of direct-to-consumer ads based on the positive results of DTC campaigns for Elidel, Zelnorm and Lamisil
Novartis Zelnorm DTC Ads To Start In Fall; Resources Shifted From Field Force
Novartis plans to launch a national DTC campaign for its irritable bowel syndrome agent Zelnorm early in the third quarter, the company announced during its July 21 investor conference call
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.